Evaluation of 5 ‑ (Tri fl uoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington ’ s Disease
暂无分享,去创建一个
G. Mcallister | C. Dominguez | V. Beaumont | O. Aziz | A. F. Haughan | I. Muñoz-Sanjuán | Scott R Pollack | M. Maillard | C. Luckhurst | P. Breccia | K. Matthews | R. Jarvis | W. Blackaby | A. Borchers | A. Stott | E. Saville-Stones | D. Vater | Rachel G. Williams | J. Vann | D. Yates | David J. Allcock | Gillian Creighton-Gutteridge | Amanda J. Van de Poel̈